Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chemistry for Tomorrow: Agility to Deliver Profound Knowledge
  • USA - English


News provided by

OMICS Group Inc.

Jun 17, 2014, 16:00 ET

Share this article

Share toX

Share this article

Share toX

Mark your Calendars for MedChem & CADD-2014 where Nobel Laureate Prof. Thomas A Steitz will present his valuable talk.
Mark your Calendars for MedChem & CADD-2014 where Nobel Laureate Prof. Thomas A Steitz will present his valuable talk.

Los Angeles, CA (PRWEB) June 17, 2014 -- MedChem & CADD-2014 warmly welcomes scientists, experts and business development executives to avail the latest innovations in the field of Medicinal Chemistry and Pharmacology with computer aided applications. This can be further elaborated as Computational Chemistry within the Pharmacological studies.

Our science quality is what we live and die by and we are in the top 0.1 per cent in the world for the research fields: 'Science and Engineering'.

Post this

MedChem & CADD-2014 is significant in many ways as it is part of International Pharma Conferences which is going to explore the Computer application in Medicinal Chemistry and Pharmacology and would like to discuss about the recent innovations and techniques in the this field. It is particularly keen in discussing about the Medicinal Chemistry with the combination of Pharmacology to unveil novel discoveries of the molecules used in treating several emblematical diseases.

Important Scientific sessions that are part of OMICS Group conference MedChem & CADD-2014 includes Rational Drug Design, Computer-Aided Drug Design and Structure Determination, Advanced Medicinal Chemistry, Quantitative Structure-Activity Relationships, Drug Development and Delivery System, Drug Interactions, Drug Metabolism, Receptors and Inhibitors, Membrane Proteins as Pharmaceutical Targets, Recent Research and Developments, and New Approaches in Drug Discovery.

Reputed speakers that are part of this conference are Dr. Victor J. Hruby, USA, Dr. Istvan J. Enyedy, Biogen Idec, USA, Dr. Concepcion Gonzalez-Bello, University of Santiago de Compostela, Spain, Dr. Kal Ramnarayan, Sapient Discovery, LLC, Dr. Pierre Falson, CNRS Research Director, Dr. Leonard Amaral, Universidade Nova de Lisboa, Portugal, Dr. Prabagaran Narayanasamy, University of Nebraska Medical Center, USA; Dr. Niren Murthy, University of California at Berkeley, USA, Dr. E. Adam Kallel, Collaborative Drug Discovery, USA, Dr. Bernhard Wunsch, Institute of Pharmaceutical and Medicinal Chemistry, Germany.

OMICS Publishing Group publishes 350 online open access journals in clinical, medical, life sciences including management, engineering, technology, and pharmaceutical fields with an aim to provide healthcare information free from the copyright barriers. OMICS Group International organizes over 150 International Scientific Conferences.

Seminars, Symposiums, Exhibitions and International Workshops are part of OMICS Group International Conferences, where the most relevant and the latest information is presented practically in the presence of eminent scholars. OMICS Group enjoys the support of a strong 30, 000 members in the editorial team and enjoys a readership of 3.5 million.

The editorial board members of the OMICS Group Journals of Medicinal Chemistry, Drug Designing: Open Access and Biochemistry & Pharmacology: Open Access, bestow their support for the MedChem & CADD-2014.

For more details on MedChem & CADD-2014 conference, please visit: http://www.pharmaceuticalconferences.com/medicinal-chemistry-aided-drug-designing-2014/index.php.

For further details, please contact:

Adam Benson
MedChem & CADD-2014
Pharmaceutical Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Office +1- 650-268-9744
Toll No +1-800-216-6499 (USA & Canada)
E-mail: medchem2014(at)omicsgroup(dot)us, medchem2014(at)omicsonline(dot)com, medchem2014(at)omicsonline(dot)us

Issac Samuel, OMICS Group Inc., http://www.omicsonline.org, +1 8888438169, [email protected]

Modal title

OMICS Worldwide Collaborations
View PDF
OMICS Worldwide Collaborations
MedChem&CADD-2014 Conference Guide
View PDF
MedChem&CADD-2014 Conference Guide
MedChem&CADD-2014
View PDF
MedChem&CADD-2014
OMICS Worldwide Collaborations MedChem&CADD-2014 Conference Guide MedChem&CADD-2014

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.